
Takeda’s Orzeyful, the first orexin agonist for narcolepsy type 1, is now available in the U.S. at a whole acquisition list price of $16,500 per 60-tablet bottle.
Alvimopan (Entereg, Adolor/GlaxoSmithKline) for the treatment of postoperative ileus.
Approvable designations
Priority review
Fast-track designations
Orphan drug designations
Non-approvable designations






